Search Results for "Grifols Biomat Employee Portal"
Original Source: Grifols, Inc.
Currently, we supply plasma products, diagnostic reagents, automated analyzers and dosing machines.In 1998, Grifols established a joint venture with a US diagnostic company, Quest International. Then, in 2000 in order to prepare for an even greater presence in the USA with its plasma products, Grifols founded Grifols USA.Grifols acquired SeraCare’s network of 45 plasmapheresis centers in 2002, thereby vertically integrating the company and guaranteeing its supply of plasma. A year later, Grifols acquired...
Matching Channels
Matching News
Annual Report for 2012 on Form 20-F filed with the SEC on April 5, 2013
BARCELONA, Spain, April 5, 2013 /PRNewswire/ -- Grifols, S.A. ("Grifols") (MCE:GRF, MCE:GRF.P and NASDAQ: GRFS), announced that it has filed its 2012 Annual Report on Form 20-F with the United States...
Return to top 50 pharma list Summary Website: Grifols Headquarters: Barcelona, Spain Ticker Symbol: GRF:Continuous SEC Link: Grifols SEC filings Subsidiaries: Araclon Biotech PlasmaCare Talecris B...
[Grifols] acquires 60% of [Progenika] for €37mm
[Grifols SA] (hemotherapy, diagnostics, and hospital IV drugs) is acquiring a 60% stake in privately held diagnostics company [Progenika Biopharma SA] for €37mm ($48mm), half of which was paid in ca...
The project will be implemented by the newly created company Gri-Cei, in which Grifols holds a 60% share and Brazilian company CEI Ltda holds the remaining 40%....
Spain's Grifols says Q1 net profit up 19 pct y/y
MADRID, May 2 (Reuters) - Spanish pharmaceutical company Grifols said on Thursday net profit rose 19 percent in the first quarter of 2013 from a year earlier to 115.7 million euros ($152.6 million), b...
Grifols acquires 40% of Spanish biotech firm VCN Bioscience
Spanish health care group Grifols (GRLS: MC), the world's third largest plasma product manufacturer, has acquired 40% of the equity of Catalan biotechnology firm VCN Biosciences, dedicated to the R&D...
Grifols signs deal to license Aradigm's Pulmaquin
MADRID, May 21 (Reuters) - Spanish drugmaker Grifols said on Tuesday it has signed an exclusive contract to license U.S. Aradigm Corporation's Pulmaquin compound and may take a stake in the California...
Cangene to sell three U.S. plasma centres to Grifols
Biotech company Cangene Corp. (TSE:CNJ) Monday announced that it has agreed to sell three U.S. plasma centres to Biomat USA Inc., a wholly-owned subsidiary of Grifols (MCE:GRF), as part of its...
Matching PubMed Articles
Relationships among supervisor feedback environment, work-related stressors, and employee deviance.
: Previous research has demonstrated that the employee deviance imposes enormous costs on organizational performance and productivity. Similar research supports the positive effect of favorable superv...
We describe a case of a ruptured hepatocellular carcinoma supplied by the portal vein that was successfully treated with portal vein embolization via a percutaneous transumbilical approach. A contrast...
We report a previously undescribed portal on the lateral aspect of the elbow-the mid-radial portal-and discuss the safety and use of this portal in a clinical practice via cadaveric dissection and ret...
The Rex shunt is a mesenteric vein to left portal vein decompressive shunt used for the treatment of portal vein thrombosis and portal hypertension. Its use has been reported primarily in the pediatri...
Idiopathic portal hypertension (IPH) is considered to be closely related to portal vein thrombosis (PVT). The aim of this study was to clarify the incidence, clinical characteristics, and outcomes of...
